Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1Phase 1/2 1

Status

Unknown 3

Sponsor Class

OTHER 23UNKNOWN 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1

Interventions

S 1 (combination) 12Capecitabine 11Paclitaxel 9Cisplatin 9apatinib 8Oxaliplatin 8pyrotinib 6nimotuzumab 6130-nm albumin-bound paclitaxel 6titanium silicide 5sintilimab 5camrelizumab 5anlotinib 5Etoposide 5Docetaxel 5Carboplatin 5Trastuzumab 4Radiotherapy, Intensity-Modulated 4Irinotecan 4Bevacizumab 4Albumin-Bound Paclitaxel 4nedaplatin 3Vinorelbine 3Temozolomide 3Tegafur 3Taxes 3Radiosurgery 3Gemcitabine 3Fluorouracil 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × nedaplatin × Clear all
NCT03603756 2020-02-11

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

ChineseAMS

Phase 2 Unknown
45 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02858206 2019-07-26

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

ChineseAMS

Phase 2 Unknown
120 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01667211 2012-08-22

CSAPPPCC

ChineseAMS

Phase 2 Unknown
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡